Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

LOGSX vs. RYHIX: which is better?

Bottom line

LOGSX vs RYHIX: the short answer

LOGSX (Live Oak Health Sciences Fund) and RYHIX (Health Care Fund) are quite different portfolios: only about 39% of their top holdings (by weight) are shared.

But RYHIX is far broader, holding 135 positions to 28 for LOGSX, so beyond the top names it adds exposure LOGSX doesn't have.

LOGSX is cheaper at 1.04% vs 1.38% — a difference of $34 a year per $10,000 invested.

Over five years, LOGSX returned +8.1% a year vs +5.1% for RYHIX.

Updated Nov 19, 2026

LOGSX vs RYHIX side by side

LOGSXRYHIX
TypeMutual fundMutual fund
Fund familyOak AssociatesGuggenheim
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.04%1.38%
Annual cost per $10k$104$138
10-yr cost on $10k (prospectus)$1,271$1,709
Max front load——
12b-1 fee—0%
1-yr return+19.6%+14.4%
5-yr return (annualized)+8.1%+5.1%
10-yr return (annualized)+7.3%+7.9%
Best quarter+13.4%+18.7%
Worst quarter−13.1%−14.4%
Net assets (fund)$56.1M$19.4M
Number of holdings28135
Portfolio turnover24%244%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearLOGSXRYHIXDifference
2025+19.6%+14.4%+5.2%
2024+0.2%+0.6%−0.4%
2023+1.2%+5.8%−4.7%
2022+3.7%−11.6%+15.3%
2021+17.5%+19.2%−1.7%
2020+6.0%+18.9%−13.0%
2019+19.0%+22.8%−3.8%
2018−4.0%+1.6%−5.5%
2017+13.4%+23.5%−10.1%
2016−0.4%−9.4%+9.0%

Source: Fund prospectus bar charts

Holdings overlap

13 of LOGSX's top 25 holdings also appear in RYHIX's top 25.

Shared top holdings
HoldingLOGSXRYHIX
Cardinal Health Inc5.86%0.86%
Amgen Inc4.86%1.56%
Mckesson Corp4.53%1.05%
Regeneron Pharmaceuticals Inc4.43%0.90%
Bristol-myers Squibb Company4.02%1.22%
Johnson & Johnson3.77%2.88%
Gilead Sciences Inc3.50%1.39%
Cigna Group (the)3.46%0.94%
Vertex Pharmaceuticals Inc3.26%1.34%
Merck & Company Inc3.16%2.04%
Intuitive Surgical Inc2.99%1.31%
Novo Nordisk A/s2.51%0.83%
Eli Lilly & Company1.99%3.63%

Source: SEC Form N-PORT

LOGSX top 10

  1. N/a — 6.91%
  2. Cardinal Health Inc — 5.86%
  3. Jazz Pharmaceuticals Plc — 5.77%
  4. United Therapeutics Corp — 5.11%
  5. Exelixis Inc — 4.95%
  6. Amgen Inc — 4.86%
  7. Lantheus Holdings Inc — 4.68%
  8. Novartis Ag — 4.67%
  9. Mckesson Corp — 4.53%
  10. Cencora Inc — 4.46%

RYHIX top 10

  1. Eli Lilly & Company — 3.63%
  2. Johnson & Johnson — 2.88%
  3. Abbvie Inc — 2.52%
  4. Unitedhealth Group Inc — 2.22%
  5. Merck & Company Inc — 2.04%
  6. Thermo Fisher Scientific Inc — 1.61%
  7. Amgen Inc — 1.56%
  8. Abbott Laboratories — 1.42%
  9. Gilead Sciences Inc — 1.39%
  10. Vertex Pharmaceuticals Inc — 1.34%

FAQ

What is the difference between LOGSX and RYHIX?
LOGSX (Live Oak Health Sciences Fund) and RYHIX (Health Care Fund) are quite different portfolios: only about 39% of their top holdings (by weight) are shared. But RYHIX is far broader, holding 135 positions to 28 for LOGSX, so beyond the top names it adds exposure LOGSX doesn't have.
Which is cheaper, LOGSX or RYHIX?
LOGSX has the lower expense ratio (1.04%).
Should I own both LOGSX and RYHIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.